Covid-19: Japanese pharmacists have good news
we may soon be pleased to hear that such drugs exist. It is a Japanese drug Avigan that Japan will provide to Ukraine for free.
Japan’s Foreign Minister ：Toshimitsu Motegi
said on April 7 that Tokyo had offered to provide anti-flu drug Avigan for free to 20 countries, including Ukraine.
He said that many states had expressed interest in the drug as it had already shown encouraging results.
However, more research is needed to prove its effectiveness.
To this end, the Government of Japan has decided to follow the proposal of other countries for the use of the drug and clinical studies of its effectiveness.
Japan’s Ambassador to Ukraine ：Takashi Kurai
said in an exclusive comment to Ukrinform that Avigan is a recognized drug for the treatment of the new type of influenza, but its effectiveness in the treatment of coronavirus infection Covid-19 has not yet been confirmed, and clinical tests are ongoing.
At the same time, the ambassador said:
“Many countries express their interest in it because there is information about a reduction in viral load due to the use of the drug and improving symptoms in patients.”
Thus, Japan has selected 20 countries to which Avigan will be provided free of charge.
These include
- Albania,
- Bulgaria,
- Georgia,
- Estonia,
- Indonesia,
- Iran,
- Cyprus,
- Kosovo,
- Luxembourg,
- Moldova,
- Myanmar,
- UAE,
- San Marino,
- Saudi Arabia,
- Serbia,
- Slovenia,
- Turkey,
- Hungary,
- Ukraine,
- the Czech Republic.
In addition, Japanese Foreign Minister Toshimitsu Motegi said on April 7 that coordination was currently being advanced with about 30 more countries.
Meanwhile, Fujifilm announced the start of clinical trials on Avigan and plans to complete them in June this year.
clinical trials are already underway in
Italy
Turkey.
Ankara even said at first
that it had received “special medicines from China to fight the coronavirus,” but these medicines then turned out to be Japanese Avigan.
UKRAINE ：DEVELOPING GENERIC COPY
By the way,
Ukraine is also working
on the development of anti-coronavirus drugs.
Microkhim, a domestic manufacturing firm that traditionally specializes in cardiology,
has recently announced the launch of work on its first domestic drug to treat coronavirus.